PINKDX LAUNCHES WITH $40 MILLION SERIES A FINANCING TO DEVELOP DIAGNOSTICS ADDRESSING UNMET MEDICAL NEEDS FOR WOMEN
The company, led by diagnostics industry veteran Bonnie Anderson,also names Alison Cowan, M.D., M.S.C.R., as chief medical officer Catalio Capital Management and The Production Board co-led the finan
PR NewswireApr 25 09:00 ET
Veracyte to Release First Quarter 2024 Financial Results on May 7, 2024
Veracyte, Inc. (NASDAQ:VCYT) announced today that it will release financial results for the first quarter of 2024 after the close of market on Tuesday, May 7, 2024. Company management will host a conference call and
BusinesswireApr 22 17:00 ET
New Study Shows Veracyte's Decipher Prostate Test Is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active Surveillance
Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that a new study published in JCO Precision Oncology shows that, among patients undergoing Active Surveillance (AS) for prostate
BusinesswireApr 22 08:30 ET
Investors Don't See Light At End Of Veracyte, Inc.'s (NASDAQ:VCYT) Tunnel
With a price-to-sales (or "P/S") ratio of 4x Veracyte, Inc. (NASDAQ:VCYT) may be sending very bullish signals at the moment, given that almost half of all the Biotechs companies in the United States h
Simply Wall StApr 17 07:33 ET
Veracyte Announces That Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024
Business WireApr 16 08:30 ET
Veracyte Is Maintained at Buy by Goldman Sachs
Veracyte Is Maintained at Buy by Goldman Sachs
Dow JonesApr 15 10:44 ET
Express News | Goldman Sachs Maintains Buy on Veracyte, Lowers Price Target to $28
Moomoo 24/7Apr 15 10:33 ET
Needham Sees BSX, CNMD, RMD Beating Street, Despite Medtech Slow Down
Seeking AlphaApr 14 17:56 ET
Express News | Veracyte Inc : Leerink Partners Cuts Target Price to $34 From $35
Moomoo 24/7Apr 12 08:05 ET
Veracyte(VCYT.US) Director Sells US$216.53K in Common Stock
$Veracyte(VCYT.US)$ Director EASTHAM KARIN sold 10,000 shares of Common Stock on Apr 1, 2024 at an average price of $21.6528 for a total value of $216.53K.Source: Announcement What is statement of cha
moomoo NewsApr 2 17:02 ET
What Makes Veracyte (VCYT) a Lucrative Investment?
Yahoo FinanceApr 2 10:33 ET
Form 144 | Veracyte(VCYT.US) Director Proposes to Sell 216.53K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 1, $Veracyte(VCYT.US)$ Director KARIN EASTHAM intends to sell 10,000 shares of its common stock on Apr 1, with a total market value of approximately $216.53K. Source: An
moomoo NewsApr 1 19:38 ET
Veracyte(VCYT.US) Director Sells US$243.6K in Common Stocks
$Veracyte(VCYT.US)$ Director JONES EVAN/ FA sold 10,000 shares of Common Stocks on Mar 1, 2024 at an average price of $24.3599 for a total value of $243.6K.Source: Announcement What is statement of ch
moomoo NewsMar 5 18:14 ET
Veracyte Files Automatic Mixed Securities Shelf
Seeking AlphaFeb 29 16:55 ET
Cathie Wood's Ark Invest Dumps $17M In Coinbase Shares As The Exchange Grappled With Disruption Amid Bitcoin Rally
On Wednesday, Cathie Wood-led Ark Invest made a significant move by selling over $17 million worth of Coinbase Global Inc (NASDAQ:COIN) shares. This decision came as the cryptocurrency exchange faced
BenzingaFeb 28 23:02 ET
Cathie Wood's Ark Invest Sheds $9.3M Worth Of Coinbase Shares Amid Bitcoin Rally — Robinhood Stock Also Sold
On Tuesday, Cathie Wood-led Ark Invest adjusted its portfolio, making significant trades. Among these, the firm's decision to sell $9.3 million worth of Coinbase Global Inc (NASDAQ:COIN) shares stood
BenzingaFeb 27 22:35 ET
Veracyte's Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN Guidelines
Veracyte, Inc. (NASDAQ:VCYT), a leading cancer diagnostics company, today announced that its Decipher Prostate Genomic Classifier is the only gene expression test to receive a "Level 1B" evidence rating in the 2024
BusinesswireFeb 27 17:55 ET
Analysts' Top Healthcare Picks: BioCryst (BCRX), Veracyte (VCYT)
TipRanksFeb 27 07:11 ET
Cathie Wood's Ark Invest Offloads $6.9M Worth of Coinbase, Robinhood Shares Each Amid Searing Bitcoin Rally — Nvidia Stock Also Shed
On Monday, Cathie Wood-led Ark Invest adjusted its portfolio, notably selling shares of cryptocurrency-related companies such as Robinhood Markets Inc (NASDAQ:HOOD) and Coinbase Global Inc (NASDAQ:COI
BenzingaFeb 26 22:45 ET
Veracyte Is Maintained at Underweight by Morgan Stanley
Veracyte Is Maintained at Underweight by Morgan Stanley
Dow JonesFeb 26 11:26 ET
No Data
No Data